Medicine and Dentistry
Blood Brain Barrier
75%
Neoplasm
56%
Magnetic Resonance Imaging
52%
Ferumoxytol
44%
Primary Central Nervous System Lymphoma
37%
Brain Tumor
30%
Central Nervous System
30%
Glioblastoma
27%
Radiation Therapy
20%
Methotrexate
19%
Perfusion Weighted Imaging
17%
Gadolinium
16%
Ultrasmall Superparamagnetic Iron Oxide
16%
Contrast Medium
15%
Metastatic Carcinoma
14%
Monoclonal Antibody
13%
Germinoma
13%
Ganglioglioma
13%
Brain Metastasis
12%
Diagnosis
11%
Intraarterial Drug Administration
11%
Carboplatin
11%
Magnetic Resonance Imaging
11%
Infusion
10%
Overall Survival
10%
Disease
10%
Tumor Progression
9%
Surgery
9%
Dynamic Susceptibility Contrast
8%
Neuro-Oncology
8%
Malignant Neoplasm
8%
Gadoteridol
8%
Clinical Trial
8%
Breast Cancer
8%
Drug Megadose
7%
Cognition
7%
Brain Cancer
7%
Nanoparticle
6%
Immunotherapy
6%
Cisplatin
6%
Lymphocyte
6%
Mannitol
6%
Chemoradiotherapy
6%
Adverse Event
5%
Macrophage
5%
Cancer
5%
Carotid Endarterectomy
5%
Bevacizumab
5%
Integrin
5%
Oligoastrocytoma
5%
Keyphrases
Blood-brain Barrier
56%
Blood-brain Barrier Disruption
54%
Primary Central Nervous System Lymphoma (PCNSL)
48%
Chemotherapy
29%
Tumor
28%
Methotrexate
20%
Ferumoxytol
19%
Central Nervous System
19%
Primary Brain Tumor
17%
Brain Tumor
15%
Monoclonal Antibody
15%
N-acetylcysteine
13%
Magnetic Resonance Imaging
13%
Nude Rat
11%
Radiotherapy
10%
Drug Delivery
10%
Carboplatin
10%
Rat Brain
10%
Collaborative Groups
10%
Intra-arterial
9%
Chemotherapy Delivery
9%
Contrast Agent
9%
Cisplatin
8%
Blood-brain Barrier Opening
8%
Sodium Thiosulfate
8%
Mannitol
8%
Ferumoxtran-10
8%
High Dose
8%
Ribonuclease
7%
Computed Tomography
7%
Ototoxicity
7%
Cerebral Tumor
7%
Iron Oxide Nanoparticles
7%
Intracarotid
7%
Chemoprotection
7%
Enhanced Cancer Therapy
7%
Dynamic Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)
7%
Neurotoxicity
7%
Rat Model
6%
Glioblastoma
6%
Neuro-oncology
6%
Ultrasmall Superparamagnetic Iron Oxide (USPIO)
6%
Perfusion Magnetic Resonance Imaging
6%
Pseudoprogression
6%
Neurophysin
6%
Normal Brain
6%
Nervous System Diseases
6%
Group Reports
5%
Renal Insufficiency
5%
Magnetic Resonance Imaging Contrast Agents
5%
Pharmacology, Toxicology and Pharmaceutical Science
Blood-Brain Barrier
100%
Chemotherapy
55%
Neoplasm
53%
Brain Tumor
43%
Methotrexate
23%
Cisplatin
22%
Ferumoxytol
18%
Carboplatin
17%
Sodium Thiosulfate
17%
Nude Rat
16%
Acetylcysteine
15%
Brain Metastasis
14%
Monoclonal Antibody
14%
Primary Central Nervous System Lymphoma
12%
Glioblastoma
11%
Hearing Impairment
11%
Cyclophosphamide
10%
Neurotoxicity
9%
Clinical Trial
9%
Ototoxicity
9%
Malignant Neoplasm
9%
Brain Cancer
8%
Rat Model
8%
Dexamethasone
8%
Iron Oxide Nanoparticle
8%
Tumor Model
7%
Contrast Medium
6%
Mannitol
6%
Doxorubicin
6%
Rituximab
6%
Iron Oxide
6%
Combination Therapy
5%
Gentamicin
5%
Immunotherapy
5%
Cytotoxicity
5%
Tumor Growth
5%
Adverse Event
5%
Nuclear Magnetic Resonance Imaging Agent
5%
Etoposide Phosphate
5%
Small Cell Lung Cancer
5%
Chemoradiation Therapy
5%
